drugset / Trial / NCT06357234

Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery

NCT06357234

Phase 2 Recruiting 100 enrolled IWK Health Centre
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This research trial will measure how useful Aprepitant is in preventing nausea and vomiting in children having surgery to correct scoliosis (curvature of the spine).

Timeline

Start
2025-03-17
Primary completion
2027-03
Completion
2027-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprepitant Other / unclassified 40 mg

Indications

No indication recorded.